Showing results (211-220 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|September 28, 2012
A new futility test approach in clinical interim data monitoringDixi XuePharmaceutical Statistics|May 25, 2023
Bayesian borrowing from historical control data in a vaccine efficacy trialLin Peng, Jing Jin, Laurent Chambonneau, et al.Pharmaceutical Statistics|February 3, 2015
Viewpoint: model selection uncertainty, pre-specification, and model averagingBjörn BornkampPharmaceutical Statistics|August 14, 2012
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosisMercier Francois, Chin Peter, Francis GordonPharmaceutical Statistics|April 15, 2021
Inverse probability of censoring weighting for visual predictive checks of time-to-event models with time-varying covariatesChristian Bartels, Thomas DumortierPharmaceutical Statistics|March 23, 2010
A flexible class of models for data arising from a 'thorough QT/QTc study'Suraj P Anand, Sujit K GhoshPharmaceutical Statistics|June 17, 2014
Missing data sensitivity analysis for recurrent event data using controlled imputationOliver N Keene, James H Roger, Benjamin F Hartley, et al.Pharmaceutical Statistics|June 17, 2014
Statistical considerations associated with a comprehensive regulatory framework to address the unmet need for new antibacterial therapiesAaron Dane, Jeffrey D WetheringtonPharmaceutical Statistics|April 8, 2015
Clinical utility estimation for assay cutoffs in early phase oncology enrichment trialsJared K LuncefordPharmaceutical Statistics|July 29, 2020
Comparing Bayesian early stopping boundaries for phase II clinical trialsLiyun Jiang, Fangrong Yan, Peter F Thall, et al.Pageof 119